Burden of caregiving for cardiovascular dysautonomia in Parkinson's disease.


Journal

Clinical autonomic research : official journal of the Clinical Autonomic Research Society
ISSN: 1619-1560
Titre abrégé: Clin Auton Res
Pays: Germany
ID NLM: 9106549

Informations de publication

Date de publication:
12 2022
Historique:
received: 13 06 2022
accepted: 18 08 2022
pubmed: 29 8 2022
medline: 7 12 2022
entrez: 28 8 2022
Statut: ppublish

Résumé

We sought to estimate the impact of cardiovascular autonomic neuropathy (cAN) on informal caregivers of patients with Parkinson's disease (PD), defined as individuals providing regular care to a friend, partner, or family member with PD, and to evaluate the mutual relationship between caregiver burden and patient health-related quality of life (HRQoL). We enrolled 36 consecutive patients with PD and their informal caregivers. Patients underwent a detailed motor, autonomic, cognitive, and functional assessment. Caregivers were assessed using the Zarit Burden Interview (ZBI). Differences in caregiver burden, expressed by the ZBI score, and strength of association between caregiver burden, cAN, and HRQoL were assessed using analysis of covariance (ANCOVA), logistic regression, and linear regression analyses. Analyses were adjusted for patients' age, PD duration, and motor and cognitive disability, as well as caregivers' age. Moderate-severe caregiver burden was reported in 41.7% of PDcAN These results highlight the significant impact of cAN on PD caregivers and the need for targeted interventions addressing this frequently overlooked and insufficiently treated source of nonmotor disability in PD.

Identifiants

pubmed: 36030471
doi: 10.1007/s10286-022-00888-9
pii: 10.1007/s10286-022-00888-9
pmc: PMC9719446
doi:

Types de publication

Journal Article

Langues

eng

Sous-ensembles de citation

IM

Pagination

455-461

Commentaires et corrections

Type : CommentIn

Informations de copyright

© 2022. The Author(s).

Références

Mov Disord. 2010 Nov 15;25(15):2649-53
pubmed: 21069833
Eur J Neurol. 2006 Sep;13(9):930-6
pubmed: 16930356
Neurology. 2015 Nov 3;85(18):1554-61
pubmed: 26432848
J Neurol. 2019 Jan;266(1):85-91
pubmed: 30382389
J Am Med Dir Assoc. 2016 Jul 1;17(7):626-32
pubmed: 27143237
J Neurol Neurosurg Psychiatry. 2019 Nov;90(11):1257-1263
pubmed: 31142660
Clin Auton Res. 2015 Oct;25(5):301-7
pubmed: 26359270
Mov Disord. 2018 Mar;33(3):391-397
pubmed: 29278286
BMC Neurol. 2012 Jul 17;12:57
pubmed: 22804846
Mov Disord. 2017 May;32(5):796-797
pubmed: 28256092
J Neurol. 1998 May;245 Suppl 1:S10-4
pubmed: 9617716
Mov Disord. 2008 Jul 15;23(9):1211-6
pubmed: 18528898
Front Neurol. 2020 Sep 02;11:897
pubmed: 32982926
Gerontologist. 1980 Dec;20(6):649-55
pubmed: 7203086
BMC Neurol. 2018 Aug 25;18(1):125
pubmed: 30144800
Parkinsonism Relat Disord. 2016 Nov;32:127-129
pubmed: 27639815
JAMA. 2014 Mar 12;311(10):1052-60
pubmed: 24618967
J Clin Neurol. 2013 Jan;9(1):1-8
pubmed: 23346153
Neurology. 2021 Aug 24;97(8):e814-e824
pubmed: 34099524
Rehabil Res Pract. 2014;2014:718527
pubmed: 25298895
Neurol Sci. 2009 Apr;30(2):171-4
pubmed: 19189044
Mov Disord. 2008 Nov 15;23(15):2129-70
pubmed: 19025984
Mov Disord. 2015 Oct;30(12):1591-601
pubmed: 26474316
Wien Med Wochenschr. 2021 Sep;171(11-12):282-288
pubmed: 33950319
J Am Geriatr Soc. 2005 Apr;53(4):695-9
pubmed: 15817019
Neurobiol Dis. 2012 Jun;46(3):572-80
pubmed: 22094370
Neurology. 2010 Nov 9;75(19):1717-25
pubmed: 21060094
Parkinsonism Relat Disord. 2018 Feb;47:45-49
pubmed: 29195729
Mov Disord. 2007 May 15;22(7):924-31; quiz 1060
pubmed: 17238193
Lancet. 2005 Apr 2-8;365(9466):1259-70
pubmed: 15811460
Br J Health Psychol. 2002 Nov;7(Part 4):481-494
pubmed: 12614498
Drugs Aging. 2006;23(9):693-721
pubmed: 17020395
Mov Disord. 2004 Nov;19(11):1306-12
pubmed: 15390007

Auteurs

Claudia Ledda (C)

Department of Neuroscience "Rita Levi Montalcini", University of Turin, Via Cherasco 15, 10126, Turin, Italy.
SC Neurologia 2U, AOU Città della Salute e della Scienza, Via Cherasco 15, 10126, Turin, Italy.

Elisa Montanaro (E)

Department of Neuroscience "Rita Levi Montalcini", University of Turin, Via Cherasco 15, 10126, Turin, Italy.
SC Neurologia 2U, AOU Città della Salute e della Scienza, Via Cherasco 15, 10126, Turin, Italy.

Gabriele Imbalzano (G)

Department of Neuroscience "Rita Levi Montalcini", University of Turin, Via Cherasco 15, 10126, Turin, Italy.
SC Neurologia 2U, AOU Città della Salute e della Scienza, Via Cherasco 15, 10126, Turin, Italy.

Aristide Merola (A)

Department of Neurology, Wexner Medical Center, Ohio State University, Columbus, OH, USA.

Ilaria Bruno (I)

Department of Neuroscience "Rita Levi Montalcini", University of Turin, Via Cherasco 15, 10126, Turin, Italy.

Carlo Alberto Artusi (CA)

Department of Neuroscience "Rita Levi Montalcini", University of Turin, Via Cherasco 15, 10126, Turin, Italy.
SC Neurologia 2U, AOU Città della Salute e della Scienza, Via Cherasco 15, 10126, Turin, Italy.

Maurizio Zibetti (M)

Department of Neuroscience "Rita Levi Montalcini", University of Turin, Via Cherasco 15, 10126, Turin, Italy.
SC Neurologia 2U, AOU Città della Salute e della Scienza, Via Cherasco 15, 10126, Turin, Italy.

Mario Giorgio Rizzone (MG)

Department of Neuroscience "Rita Levi Montalcini", University of Turin, Via Cherasco 15, 10126, Turin, Italy.
SC Neurologia 2U, AOU Città della Salute e della Scienza, Via Cherasco 15, 10126, Turin, Italy.

Marco Bozzali (M)

Department of Neuroscience "Rita Levi Montalcini", University of Turin, Via Cherasco 15, 10126, Turin, Italy.
SC Neurologia 2U, AOU Città della Salute e della Scienza, Via Cherasco 15, 10126, Turin, Italy.

Gabriele Sobrero (G)

Department of Medical Sciences, Internal Medicine Division, Autonomic Unit and Hypertension Unit, University of Turin, Turin, Italy.

Fabrizio Vallelonga (F)

Department of Medical Sciences, Internal Medicine Division, Autonomic Unit and Hypertension Unit, University of Turin, Turin, Italy.

Simona Maule (S)

Department of Medical Sciences, Internal Medicine Division, Autonomic Unit and Hypertension Unit, University of Turin, Turin, Italy.

Leonardo Lopiano (L)

Department of Neuroscience "Rita Levi Montalcini", University of Turin, Via Cherasco 15, 10126, Turin, Italy.
SC Neurologia 2U, AOU Città della Salute e della Scienza, Via Cherasco 15, 10126, Turin, Italy.

Alberto Romagnolo (A)

Department of Neuroscience "Rita Levi Montalcini", University of Turin, Via Cherasco 15, 10126, Turin, Italy. al.romagnolo@gmail.com.
SC Neurologia 2U, AOU Città della Salute e della Scienza, Via Cherasco 15, 10126, Turin, Italy. al.romagnolo@gmail.com.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH